Back

SYNE1 gene novel variant is associated with myocardial infarction in young people with a family history of premature atherosclerosis.

27 August 2023 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Genetics Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Associate Professor Michal Ambroziak

The Medical Centre of Postgraduate Education, Warsaw (Poland)

7 More presentations in this session

Presentation thumbnail
Genome-wide association meta-analysis of 5,864 individuals highlights 25 new loci implicated in the pathogenesis of cancer therapy-related cardiac dysfunction
Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Assessment of multi-trait analysis of GWAS (MTAG) for discovery of novel genetic variants and mechanistic insight in common cardiovascular diseases
Doctor P. Jorda (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Large-scale genetic and multi-omics analyses identify molecular pathways underlying dilated cardiomyopathy
Mr S. Jurgens (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Glu298Asp variant of endothelial nitric oxide synthase gene and acute or early presentation of coronary artery disease: An updated systematic review and meta-analysis
Doctor H. Rai (Dublin 7, IE)
Abstract Slides Video
Presentation thumbnail
Haematopoietic loss of KDM6A impairs cardiac recovery post myocardial infarction via pro-inflammatory myeloid cells
Doctor E. Solomonidis (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Genetics

The Event

Event poster

ESC Congress 2023

27 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of genetic mutations and polymorphisms with coronary artery disease
thumbnail
Congress Presentation
Genetic predictors of unfavorable prognosis in patients with low and moderate cardiovascular risk with high adherence to treatment
thumbnail
Congress Presentation
Screening program for familial dyslipidemias in patients with ischemic heart disease. cost-effectiveness of genetic testing.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources